Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
$962M |
| 2 |
Cisco
CSCO
|
$202M |
| 3 |
Amazon
AMZN
|
$165M |
| 4 |
Johnson & Johnson
JNJ
|
$153M |
| 5 |
Pinduoduo
PDD
|
$131M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$468M |
| 2 |
Merck
MRK
|
$306M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$305M |
| 4 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
$299M |
| 5 |
TRTN
Triton International Limited
TRTN
|
$282M |
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Financials | 17.12% |
| 3 | Industrials | 13% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Franklin Wireless
FKWL
$48.1M
| $79.7K | ﹤0.01% |
23,499
| – | – |
|
3302
Precigen
PGEN
$1.42B
| $78.9K | ﹤0.01% |
58,755
| – | – |
|
3303
CPS Technologies
CPSH
$50.4M
| $78.9K | ﹤0.01% |
33,581
| – | – |
|
|
BMTX
3304
DELISTED
BM Technologies, Inc.
BMTX
| $76.3K | ﹤0.01% |
37,213
-11,849
| -24% | -$24.3K |
|
|
IMA
3305
ImageneBio, Inc. Common Stock
IMA
$153M
| $76.3K | ﹤0.01% |
38,633
-46,982
| -55% | -$92.8K |
|
3306
Sono-Tek
SOTK
$56.5M
| $75.5K | ﹤0.01% |
14,546
| – | – |
|
|
CBD
3307
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $73.5K | ﹤0.01% |
91,838
-9,579
| -9% | -$7.66K |
|
3308
WidePoint Corp
WYY
$47.1M
| $72.6K | ﹤0.01% |
31,284
| – | – |
|
3309
Capricor Therapeutics
CAPR
$287M
| $72.6K | ﹤0.01% |
14,839
-9,246
| -38% | -$45.2K |
|
|
TPIC
3310
DELISTED
TPI Composites
TPIC
| $72.3K | ﹤0.01% |
17,462
-341,781
| -95% | -$1.41M |
|
|
ORKA
3311
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
| $72.3K | ﹤0.01% |
42,514
| – | – |
|
|
WHWK
3312
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $72K | ﹤0.01% |
35,595
-15,660
| -31% | -$31.7K |
|
3313
Exagen
XGN
$213M
| $71.7K | ﹤0.01% |
36,030
-18,369
| -34% | -$36.6K |
|
3314
OptimumBank Holdings
OPHC
$49.6M
| $71.2K | ﹤0.01% |
17,154
| – | – |
|
3315
Rallybio
RLYB
$24.1M
| $70.8K | ﹤0.01% |
29,643
-3,158
| -10% | -$7.55K |
|
3316
Assertio
ASRT
$78M
| $70.6K | ﹤0.01% |
65,997
| – | – |
|
3317
PureCycle Technologies
PCT
$2.39B
| $69.5K | ﹤0.01% |
17,151
-153
| -0.9% | -$620 |
|
3318
Lightpath Technologies
LPTH
$239M
| $68.7K | ﹤0.01% |
54,543
| – | – |
|
3319
Flux Power
FLUX
$26.8M
| $68.7K | ﹤0.01% |
16,718
| – | – |
|
|
IMAB
3320
I-MAB
IMAB
$380M
| $68.6K | ﹤0.01% |
36,123
| – | – |
|
3321
Blend Labs
BLND
$887M
| $68.3K | ﹤0.01% |
26,766
| – | – |
|
3322
Arts-Way Manufacturing Co
ARTW
$16.9M
| $67.6K | ﹤0.01% |
32,199
+4,916
| +18% | +$10.3K |
|
3323
SurgePays
SURG
$55.3M
| $67.3K | ﹤0.01% |
10,432
| – | – |
|
3324
CEL-SCI Corp
CVM
$81.4M
| $67.3K | ﹤0.01% |
24,730
| – | – |
|
3325
OPAL Fuels
OPAL
$65.2M
| $65.7K | ﹤0.01% |
+11,894
| New | +$65.7K |
|